Sharps Technology Inc. (STSS) Dividend History

Company News

• Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule

  Sharps Technology, a medical device and pharmaceutical packaging company, has received its first purchase orders for its SecureGard and SoloGard products, marking its transition from the pre-revenue qualification phase to revenue-generating commercial operations.

  GlobeNewswire Inc.
• Sharps Technology Announces Reverse Stock Split

  Sharps Technology, Inc. announced a 1-for-300 reverse stock split to bring the company into compliance with Nasdaq's minimum bid price requirement. The reverse split will reduce the authorized common shares from 500,000,000 to 1,666,667.

  GlobeNewswire Inc.
• Sharps Technology’s CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary

  Sharps Technology secures $20 million in financing, advancing manufacturing capabilities in Hungary to accelerate shipments under existing agreements for SecureGard and SoloGard products. The company is well-positioned to capitalize on growing demand for innovative injection solutions.

  GlobeNewswire Inc.
• Sharps Technology’s CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue

  Sharps Technology, Inc. announces plans to expand its manufacturing facility in Hungary to increase production of its SecureGard and SoloGard syringe products, driven by a $50+ million sales agreement with a US-based pharma company and growing demand for its innovative injection solutions.

  GlobeNewswire Inc.
• Sharps Technology, Inc. Announces $3.5 Million Bridge Financing

  Sharps Technology, Inc. (NASDAQ: STSS) announced a $3.5 million secured bridge loan financing, which will be used for general corporate purposes and working capital.

  GlobeNewswire Inc.